Comparative CV Effectiveness of GLP-1s and SGLT2 Inhibitors in T2DM
A multinational, retrospective, new-user active-comparator cohort study using 10 U.S. and non-U.S. administrative claims and EHR databases. JACC
Original Source
Read the full article at Medscape →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.